Table 1 Patients population.
Gender | N (M/F) | 26/26 |
Age | years, mean (min–max) | 50 (21–65) |
Body weight | kg, mean (min–max) | 105 (74–162) |
Body mass index | kg/m2, mean (min–max) | 36 (30–56) |
Waist | cm, mean (min–max) | 116 (95–168) |
Antidiabetic drug | N (%) | 15 (29) |
Antihypertensive treatment | N (%) | 35 (67) |
ALAT | UI/L, mean (min–max) | 41 (8–130) |
ASAT | UI/L, mean (min–max) | 27 (10–67) |
γGT | UI/L, mean (min–max) | 47 (9–144) |
Fasting triglyceride | mg/dL, mean (min–max) | 153 (53–328) |
Fasting blood glucose | mg/dL, mean (min–max) | 105 (80–176) |
